PineBridge Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

PineBridge Investments’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-31,979	Closed	-$616K	–	772
2019 Q4	$616K	Sell	31,979 -11,952	-27%	-$229K	0.01%	810
2019 Q3	$871K	Buy	43,931 +5,318	+14%	+$111K	0.01%	800
2019 Q2	$815K	Buy	+38,613	New	+$807K	0.01%	739
2019 Q1	–	Sell	-3,597	Closed	-$72K	–	1075
2018 Q4	$72K	Buy	3,597 +2,676	+291%	+$52.7K	﹤0.01%	914
2018 Q3	$18K	Buy	+921	New	+$16.4K	﹤0.01%	1052
2017 Q4	–	Sell	-4,414	Closed	-$79K	–	1038
2017 Q3	$79K	Sell	4,414 -286	-6%	-$4.71K	﹤0.01%	985
2017 Q2	$84K	Buy	4,700 +17	+0.4%	+$270	﹤0.01%	954
2017 Q1	$68K	Buy	4,683 +151	+3%	+$2.37K	﹤0.01%	986
2016 Q4	$84K	Buy	+4,532	New	+$88.2K	﹤0.01%	1009

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

PineBridge Investments's AMPH Position: Q1 2020 in Review

PineBridge Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2020, closing a stake of 31,979 shares — an estimated $616K sold.

PineBridge Investments first reported a position in AMPH in Q4 2016 and held it in 9 quarters. The position peaked at $871K in Q3 2019. 111 funds tracked by Wall St. Rank hold AMPH as of Q1 2020.

PineBridge Investments reported no remaining Amphastar Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
PineBridge Investments sold 31,979 Amphastar Pharmaceuticals shares in Q1 2020, an estimated $616K.
PineBridge Investments first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 9 quarters.
PineBridge Investments's Amphastar Pharmaceuticals position peaked at $871K in Q3 2019.
111 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2020.

Based on PineBridge Investments's 13F filing for Q1 2020, filed 14 May 2020.